Form4insider filings, from the source

Company · CIK 0001584137 · SIC 2834 — Pharmaceutical Preparations

Oncolix, Inc. · ONCX

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $0 · 0sales $313k · 1net −$313k
$10k$10k$100k$100k$1M$1MbuyssalesApr 3Apr 3Apr 3Apr 4Apr 4Apr 4Apr 5

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 26, 2017 MForm 4 →Sep 26, 10:26 am EDTJ Donald PayneSecretary, Director200,000$0.005$1,0002,028,000— plan?
Aug 3, 2017 ADForm 4 →Sep 14, 12:58 pm EDTMichael Thomas RedmanPresident, Director65,879,130——2,828,000— plan? late
Aug 3, 2017 ADForm 4 →Aug 7, 1:03 pm EDTJ Donald PayneSecretary, Director61,879,130——2,028,000— plan?
Apr 4, 2017 SForm 4/A →Jul 6, 6:12 pm EDTBrian K KistlerOther61,465,730$0.0051$313,4750−100% plan?
Apr 4, 2017 SForm 4/A →Apr 14, 10:28 am EDTBrian K KistlerOther61,465,730$0.0051$313,4750−100% plan? amended
Apr 4, 2017 SForm 4 →Apr 12, 4:02 pm EDTBrian K KistlerOther61,465,730$0.0051$313,4750−100% plan? late amended
Mar 7, 2017 JForm 4/A →Jul 6, 6:12 pm EDTBrian K KistlerOther60,000,000$0.0019$114,00061,465,730— plan?
Mar 7, 2017 MForm 4/A →Apr 14, 10:28 am EDTBrian K KistlerOther60,000,000$0.0019$114,00061,465,730— plan? amended
Mar 7, 2017 PForm 4 →Apr 12, 4:02 pm EDTBrian K KistlerOther60,000,000$0.0019$114,00061,465,730+4,094% plan? late amended

Reported at this company — derivatives (options, RSUs, warrants)

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 26, 2017 MForm 4 →Sep 26, 10:26 am EDTJ Donald PayneSecretary, Director200,000$0.005$1,0001,400,000—
Aug 3, 2017 AForm 4 →Sep 14, 12:58 pm EDTMichael Thomas RedmanPresident, Director4,828,000——4,800,000— late
Aug 3, 2017 AForm 4 →Aug 7, 1:03 pm EDTJ Donald PayneSecretary, Director1,628,000——1,600,000—